Results 1 to 10 of about 849,373 (191)

Thyroid Dysfunction Associated with Administration of the Long-Acting Gonadotropin-Releasing Hormone Agonist [PDF]

open access: yesEndocrinology and Metabolism, 2013
Gonadotropin-releasing hormone (GnRH) agonist has been used in the treatment of a wide variety of sex-hormone-related diseases, as the administration of GnRH agonist can alter the secretion of gonadotropin and sex hormones.
Eun Jin Han   +6 more
doaj   +2 more sources

Pituitary Apoplexy Following Gonadotropin‐Releasing Hormone Agonist Administration for Prostate Cancer [PDF]

open access: yesIJU Case Reports
Introduction Pituitary apoplexy represents an uncommon endocrine emergency with potentially life‐threatening consequences. Gonadotropin‐releasing hormone agonist used for prostate cancer has the potential to induce pituitary apoplexy, particularly in the
Masaaki Fujimura   +5 more
doaj   +2 more sources

Gonadotropin-releasing hormone agonist contributes to the successful implementation of in vitro fertilization in a patient with cervical endometriosis: a case report

open access: yesAJOG Global Reports, 2023
This is a case report of a nulliparous young woman who suffered from prolonged menstruation and infertility for 1 year. Magnetic resonance imaging and a transvaginal ultrasound examination revealed cervical endometriosis.
Turui Yang, MD   +4 more
doaj   +2 more sources

Gonadotropin-releasing hormone analogs: Understanding advantages and limitations

open access: yesJournal of Human Reproductive Sciences, 2014
Pituitary stimulation with pulsatile gonadotropin-releasing hormone (GnRH) analogs induces both follicle-stimulating hormone (FSH) and luteinizing hormone (LH).
Pratap Kumar, Alok Sharma
doaj   +2 more sources

Gonadotropin releasing hormone analogs as part of controlled ovarian stimulation

open access: yesF&S Reports, 2023
I describe how we identified the need to block the luteinizing hormone (LH) surge when trying to control the processes of luteinization and ovulation within the clinic.
Richard Fleming, Ph.D.
doaj   +2 more sources

Beneficial Effect of Luteal-phase Gonadotropin-releasing Hormone Agonist Administration on Implantation Rate Afterintracytoplasmic Sperm Injection

open access: yesTaiwanese Journal of Obstetrics & Gynecology, 2009
Objective: To evaluate the effect of gonadotropin-releasing hormone (GnRH) agonist, administered in the luteal phase, on intracytoplasmic sperm injection (ICSI) outcome.
Dehghani Firouzabadi Razieh   +2 more
doaj   +2 more sources

Gonadotropin-releasing hormone agonist-induced pituitary apoplexy

open access: yesEndocrinology, Diabetes & Metabolism Case Reports, 2016
Pituitary apoplexy represents an uncommon endocrine emergency with potentially life-threatening consequences. Drug-induced pituitary apoplexy is a rare but important consideration when evaluating patients with this presentation.
Fergus Keane   +4 more
doaj   +2 more sources

Aggressive angiomyxoma of the vulva: dramatic response to gonadotropin-releasing hormone agonist therapy

open access: yesJournal of Research in Medical Sciences, 2007
<p>Aggressive angiomyxoma is a rare soft tissue neoplasm that usually arises within the perineum. It often occurs as a vulvar mass and clinically simulates a Bartholin&#39;s gland cyst.
Azar Danesh, Mohammad Hossein Sanei
doaj   +1 more source

Ovarian Cyst Formation Following Gonadotropin-Releasing Hormone-Agonist Administration Decreases the Oocyte Quality in IVF Cycles

open access: yesBalkan Medical Journal, 2012
Objective: The gonadotropin-releasing hormone-agonist (GnRH-a) treatment during in vitro fertilization (IVF) sometimes causes a functional ovarian cyst during the administration period before gonadotropin stimulation, as an undesired event.
Muammer Doğan   +5 more
doaj   +2 more sources

Effects of gonadotropin-releasing hormone agonist treatment on final adult height in boys with idiopathic central precocious puberty [PDF]

open access: yesAnnals of Pediatric Endocrinology & Metabolism, 2021
Purpose There are few reports on the therapeutic effects of gonadotropin-releasing hormone agonists in boys with central precocious puberty, and studies reported in Korea are very rare.
Ah Young Cho   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy